Literature DB >> 15602551

Navigating chemical space for biology and medicine.

Christopher Lipinski1, Andrew Hopkins.   

Abstract

Despite over a century of applying organic synthesis to the search for drugs, we are still far from even a cursory examination of the vast number of possible small molecules that could be created. Indeed, a thorough examination of all 'chemical space' is practically impossible. Given this, what are the best strategies for identifying small molecules that modulate biological targets? And how might such strategies differ, depending on whether the primary goal is to understand biological systems or to develop potential drugs?

Mesh:

Substances:

Year:  2004        PMID: 15602551     DOI: 10.1038/nature03193

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  169 in total

Review 1.  Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.

Authors:  Na'ama A Shein; Esther Shohami
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

2.  Gaining confidence in high-throughput screening.

Authors:  Jérôme Bibette
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  A reverse combination of structure-based and ligand-based strategies for virtual screening.

Authors:  Alvaro Cortés-Cabrera; Federico Gago; Antonio Morreale
Journal:  J Comput Aided Mol Des       Date:  2012-03-07       Impact factor: 3.686

4.  Drug discovery: Know your chemical space.

Authors:  Andrew L Hopkins; G Richard Bickerton
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

5.  Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles.

Authors:  Paul A Clemons; Nicole E Bodycombe; Hyman A Carrinski; J Anthony Wilson; Alykhan F Shamji; Bridget K Wagner; Angela N Koehler; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

6.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.

Authors:  Warren R J D Galloway; Albert Isidro-Llobet; David R Spring
Journal:  Nat Commun       Date:  2010-09-21       Impact factor: 14.919

Review 7.  Fine-tuning multiprotein complexes using small molecules.

Authors:  Andrea D Thompson; Amanda Dugan; Jason E Gestwicki; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2012-07-23       Impact factor: 5.100

8.  Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.

Authors:  Aditi Bapat; Lateca S Glass; Meihua Luo; Melissa L Fishel; Eric C Long; Millie M Georgiadis; Mark R Kelley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-26       Impact factor: 4.030

Review 9.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

10.  A convergent, modular approach to functionalized 2,1-borazaronaphthalenes from 2-aminostyrenes and potassium organotrifluoroborates.

Authors:  Steven R Wisniewski; Courtney L Guenther; O Andreea Argintaru; Gary A Molander
Journal:  J Org Chem       Date:  2013-12-11       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.